Drug addiction Flashcards
Name 3 stimulants
Amphetamine, Cocaine, Nicotine
Name 3 Depressants
Alcohol, Opiates & Sedatives
Name 3 Hallucinogens
LSD, Magic Mushrooms, & Mescaline
What two groups does Ecstasy (MDMA) fall under?
Stimulants & Hallucinogens
What neurotransmitters do stimulants affect? (2)
Dopamine & Noradrenaline activity (increases)
What neurotransmitters do depressants affect? (3)
GABA, Dopamine & Serotonin activity (increases)
What neurotransmitters do hallucinogens affect?
(2)
Serotonin & Acetylcholine activity (increases)
What are the subjective effects of stimulants? (4)
Energy, Euphoria, Alertness & Confidence
What subjective effects do depressants have? (4)
Sleepiness, Confusion, Euphoria, Warmth
What subjective effects do hallucinogens have? (3)
Altered Perception, Thoughts & Feelings
Addictive potential of stimulants
HIGH
Addictive potential of depressants
HIGH
Addictive potential of hallucinogens
LOW
What can Ecstasy (MDMA) do?
Increase alertness, talkativeness & affection. Music & colours seem more intense.
The biological reward pathway is:
The Medial Forebrain Bundle (MFB)
In order to have direct effects on the Central Nervous System, drugs must be able to cross the…?
Blood Brain Barrier (BBB)
What is the Blood Brain Barrier?
A protective layer that lines the inner surfaces of the blood vessels inside your brain. (Basically a filter)
What does the BBB control?
Substances that can enter or leave the nervous tissue
What is the BBB a barrier between?
The bloodstream and the extra cellular space of the brain
What is unique about the BBB’s Endothelial cells?
The cells that make up the BBB are tightly-fused together to restrict diffusion across the vessel lining
What is involved with signalling the Endothelial cells to tighten in the BBB?
The Astrocytic End-Feet
What does Epigenetic mean?
The environment can influence genetics
What do we call it when individuals are unable to produce the same ‘reward’ feeling others get when taking drugs?
Reward Deficiency Syndrome
What causes Reward Deficiency Syndrome?
Insufficient monoaminergic neurotransmitter turnover